Pfizer to stop selling vaccines in China

 02-Apr-15, Fortune

It’s getting harder and harder to get drugs approved in a market that every major drug company needs access to.

Pfizer Inc said Thursday it will cease its vaccines sales operations in China after an import licence for one of its top-selling treatments, the only vaccine it sold in the country, was not renewed.

Image: Fortune

The move comes as drugmakers face growing difficulties obtaining approvals for medicines in China, the world’s No. 2 drug market, where pharmaceutical executives say over-stretched regulators have added more red tape to the process of bringing drugs to market.

 Read the full article

 Insights